Anti-MYF5 Rabbit Monoclonal Antibody

Overview

This product is an anti-MYF5 antibody for target detection and characterization. Key identifiers include host species: Rabbit; Monoclonal; clone 24M01; isotype IgG; reactivity: Human,Mouse,Rat. Reported application contexts include WB, IP (as provided in the source record). Boster Bio Anti-MYF5 Rabbit Monoclonal Antibody catalog # M04040-1. Tested in WB, IP applications. This antibody reacts with Human, Mouse, Rat.

Key elements and design rationale

• Target: MYF5 (Mitochondrial import receptor subunit TOM20 homolog).
• Antibody format: Monoclonal; clone 24M01; isotype IgG.
• Host: Rabbit.
• Species reactivity: Human,Mouse,Rat (confirm in your model system with appropriate controls).

This description is intended to help interpret the antibody design and the biological context of the target using the fields provided in the catalog record, alongside general experimental considerations.

Biological background

MYF5 (protein: T-cell surface glycoprotein CD3 zeta chain) is a commonly studied target in molecular and cellular biology. Functional context (as provided): Central component of the receptor complex responsible for the recognition and translocation of cytosolically synthesized mitochondrial preproteins. Together with TOM22 functions as the transit peptide receptor at the surface of the mitochondrion outer membrane and facilitates the movement of preproteins into the TOM40 translocation pore (By similarity). . Reported cellular localization context: Mitochondrion outer membrane ; Single-pass membrane protein . Tissue expression notes (as provided): Mainly expressed in endothelial cells lining lymphatic vessels. .

Research relevance and current trends

• Research context keywords from the source record include: Cancer,Metabolism,Mitochondrial,Mitochondrial Markers,Mitochondrial Metabolism,Pathways and Processes,Protein Trafficking,Signal Transduction,Vesicle Transport.
• Current studies often focus on connecting target abundance/localization to pathway perturbations across models, tissues, and cell states.
• Quantitative and multiplexed assays (e.g., imaging + immunoblot panels) are commonly used to compare phenotypes across conditions and time-courses.

Common research applications

• Western blotting (WB): assess relative target abundance across samples, treatments, or time-points.
• Immunoprecipitation (IP): enrich target complexes for downstream immunoblot or interaction analyses.

Workflow ideas (metafield): Validate MYF5 antibody specificity using KO/KD control samples (WB/IF/IHC as appropriate), Detect MYF5 expression by Western blot in cell or tissue lysates, Enrich MYF5 by immunoprecipitation from lysates for downstream analysis

Notes for experimental interpretation

• Consider isoforms and post-translational modifications (PTMs) that may shift apparent molecular weight or epitope accessibility.
• Apparent molecular weight may vary by sample type and processing (observed MW: 37 kDa; calculated MW: 16298 MW).
• Control concepts: include appropriate negative controls (e.g., isotype, KO/KD samples) and orthogonal validation when feasible.

Additional product details (from the source record)

• Molecular weight (observed): 37 kDa
• Cellular localization (provided): Mitochondrion outer membrane ; Single-pass membrane protein .
• Tissue details (provided): Mainly expressed in endothelial cells lining lymphatic vessels. .

Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.